Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

370 ARTÍCULOS , VIENDO DEL 136 AL 150

Short-Term Response to Cholinesterase Inhibitors in Alzheimer's Disease Delays Time to Nursing Home Placement

Wattmo C, Londos E, Minthon L.

Curr Alzheimer Res. 2018;15(10):905-916. doi: 10.2174/1567205015666180507105326.

Recent advancements in the field of nanotechnology for the delivery of anti-Alzheimer drug in the brain region

Agrawal M, Saraf S, Saraf S, Antimisiaris SG, Hamano N, Li SD, Chougule M, Shoyele SA, Gupta U, Ajazuddin, Alexander A.

Expert Opin Drug Deliv. 2018 Jun;15(6):589-617. doi: 10.1080/17425247.2018.1471058. Epub 2018 May 17.

The interactions of p53 with tau and Aß as potential therapeutic targets for Alzheimer's disease

Jazvinšćak Jembrek M, Slade N, Hof PR, Šimić G.

Prog Neurobiol. 2018 Sep;168:104-127. doi: 10.1016/j.pneurobio.2018.05.001. Epub 2018 May 4.

Benzofuran and Indole: Promising Scaffolds for Drug Development in Alzheimer's Disease

Goyal D, Kaur A, Goyal B.

ChemMedChem. 2018 Jul 6;13(13):1275-1299. doi: 10.1002/cmdc.201800156. Epub 2018 Jun 19.

Spore powder of Ganoderma lucidum for the treatment of Alzheimer disease: A pilot study

Wang GH, Wang LH, Wang C, Qin LH.

Medicine (Baltimore). 2018 May;97(19):e0636. doi: 10.1097/MD.0000000000010636.

The Impact of a Long-Term Rivastigmine and Donepezil Treatment on All-Cause Mortality in Patients With Alzheimer's Disease

Kazmierski J, Messini-Zachou C, Gkioka M, Tsolaki M.

Am J Alzheimers Dis Other Demen. 2018 Sep;33(6):385-393. doi: 10.1177/1533317518775044. Epub 2018 May 9.

Passive Aβ Immunotherapy: Current Achievements and Future Perspectives

Schilling S, Rahfeld JU, Lues I, Lemere CA.

Molecules. 2018 May 3;23(5):1068. doi: 10.3390/molecules23051068.

Network Medicine for Alzheimer's Disease and Traditional Chinese Medicine

Jarrell JT, Gao L, Cohen DS, Huang X.

Molecules. 2018 May 11;23(5):1143. doi: 10.3390/molecules23051143.

Alzheimer's Disease, Dendritic Spines, and Calcineurin Inhibitors: A New Approach?

O'Neal MA, Stallings NR, Malter JS.

ACS Chem Neurosci. 2018 Jun 20;9(6):1233-1234. doi: 10.1021/acschemneuro.8b00213. Epub 2018 May 14.

Lost in Translation? Finding Our Way To Effective Alzheimer's Disease Therapies

Quinn JF.

J Alzheimers Dis. 2018;64(s1):S33-S39. doi: 10.3233/JAD-179930.

A novel cognitive disease progression model for clinical trials in autosomal-dominant Alzheimer's disease

Wang G, Berry S, Xiong C, Hassenstab J, Quintana M, McDade EM, Delmar P, Vestrucci M, Sethuraman G, Bateman RJ; Dominantly Inherited Alzheimer Network Trials Unit.

Stat Med. 2018 Sep 20;37(21):3047-3055. doi: 10.1002/sim.7811. Epub 2018 May 14.

Modulation of functional activity and connectivity by acupuncture in patients with Alzheimer disease as measured by resting-state fMRI

Zheng W, Su Z, Liu X, Zhang H, Han Y, Song H, Lu J, Li K, Wang Z.

PLoS One. 2018 May 15;13(5):e0196933. doi: 10.1371/journal.pone.0196933. eCollection 2018.

A review on flavonoid-based scaffolds as multi-target-directed ligands (MTDLs) for Alzheimer's disease

Jalili-Baleh L, Babaei E, Abdpour S, Nasir Abbas Bukhari S, Foroumadi A, Ramazani A, Sharifzadeh M, Abdollahi M, Khoobi M.

Eur J Med Chem. 2018 May 25;152:570-589. doi: 10.1016/j.ejmech.2018.05.004. Epub 2018 May 7.

The modern role of antipsychotics for the treatment of agitation and psychosis in Alzheimer's disease

Creese B, Da Silva MV, Johar I, Ballard C.

Expert Rev Neurother. 2018 Jun;18(6):461-467. doi: 10.1080/14737175.2018.1476140. Epub 2018 May 21.

Stem Cells in Alzheimer's Disease: Current Standing and Future Challenges

Salem H, Colpo GD, Teixeira AL.

Adv Exp Med Biol. 2018;1079:93-102. doi: 10.1007/5584_2018_214.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias